...
首页> 外文期刊>Saudi Pharmaceutical Journal >Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer
【24h】

Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer

机译:5-氟尿嘧啶肠溶纳米颗粒的制备与表征,用于缓释和局部释放治疗大肠癌

获取原文

摘要

5-Fluorouracil is used in the treatment of colorectal cancer along with oxaliplatin as first line treatment, but it is having lack of site specificity and poor therapeutic effect. Also toxic effects to healthy cells and unavailability of major proportion of drug at the colon region remain as limitations. Toxic effects prevention and drug localization at colon area was achieved by preparing enteric-coated chitosan polymeric nanoparticles as it can be delivered directly to large bowel. Enteric coating helps in preventing the drug degradation at gastric pH. So the main objective was to prepare chitosan polymeric nanoparticles by solvent evaporation emulsification method by using different ratios of polymer (1:1, 1:2, 1:3, 1:4). Optimized polymer ratio was characterized by differential scanning calorimetry (DSC), X-ray diffraction (XRD), entrapment efficiency and particle size and further subjected to enteric coating. In vitro drug release studies were done using dialysis bag technique using simulated fluids at various pH (1.2, 4.5, 7.5, 7.0) to mimic the GIT tract. 5-FU nanoparticles with drug: polymer ratio of 1:2 and 1:3 has shown better particle size (149+/-1.28nm and 138+/-1.01nm respectively), entrapment efficiency (48.12+/-0.08% and 69.18+/-1.89 respectively). 5-FU E1 has shown better drug release after 4h and has shown 82% drug release till 24h in a sustained manner comparable to the non-enteric coated tablets, which released more than 50% of the drug before entering the colon region. So we can conclude that nanoparticles prepared by this method using the same polymer with the optimized ratio can represent as potential drug delivery approach for effective delivery of the active pharmaceutical ingredient to the colorectal tumors.
机译:5-氟尿嘧啶与奥沙利铂作为一线治疗药物一起用于结直肠癌的治疗,但是它缺乏位点特异性并且治疗效果差。对健康细胞的毒性作用以及在结肠区域无法获得大部分药物仍然是局限性。通过制备肠溶衣的壳聚糖聚合物纳米颗粒,可将其直接递送到大肠中,从而实现了在结肠区域的毒性预防和药物定位。肠溶衣有助于防止药物在胃pH值下降解。因此,主要目的是通过溶剂蒸发乳化法,采用不同比例的聚合物(1:1、1:2、1:3、1:4)制备壳聚糖聚合物纳米颗粒。通过差示扫描量热法(DSC),X射线衍射(XRD),包封率和粒径来表征最佳的聚合物比例,并进一步进行肠溶衣。使用透析袋技术进行体外药物释放研究,使用各种pH(1.2、4.5、7.5、7.0)的模拟液体模拟GIT道。药物:聚合物比为1:2和1:3的5-FU纳米颗粒显示出更好的粒径(分别为149 +/- 1.28nm和138 +/- 1.01nm),包封效率(48.12 +/- 0.08%和69.18分别为+/- 1.89)。 5-FU E1在4h后显示了更好的药物释放,并且在24h之前持续显示出82%的药物释放,这与非肠溶片相似,后者在进入结肠区域之前释放了50%以上的药物。因此,我们可以得出结论,通过这种方法使用相同的聚合物以最佳比例制备的纳米颗粒可以代表潜在的药物递送方法,以有效地将活性药物成分递送至结肠直肠肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号